Post-Surgery Immunotherapy Boosts Kidney Cancer Survival Rates miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Credit: Pixabay/CC0 Public Domain For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survi .
Frontline treatment with Keytruda and Cabometyx produced responses with a manageable safety profile in patients with cisplatin-ineligible urothelial carcinoma, a type of bladder cancer.